Eiqus

About Eiqus

EIQUS is a French deeptech company in health, building the reference measure of how people cope under pressure: observed in the field, scored by a psychologist, scaled by software. The core is PSCE®, a patented protocol (two French patents, international application WO2022195130). In a structured session with a horse, led by a psychologist, a person's behaviour is observed and scored on a standardised grid across four dimensions: physiological, social, cognitive and emotional. A horse responds to posture and tension, not to words, so the signal is hard to fake. 416 scored evaluations already form a proprietary dataset. The stack: - EIQUS Connect, our tablet scoring tool, runs in every session and produces the evaluation report. - A data platform, now in build with our development partner, brings session data, consent and dashboards together from tablet to cloud. Its class I medical-device qualification (EU MDR) starts shortly. - EIQUS Flow, a between-session app, pilots in November 2026; its production version will be hosted in France. - Next, an AI engine for assisted scoring, automated reports and links to hospital records, then a modular sensory capsule that takes the protocol off site. Both are financed by €490k of interest-free public funding (€129k of it non-repayable) through our affiliate, under a grant contract signed on 4 November 2026; the programme runs to November 2028. Bpifrance Deep Tech label. €491k invested in R&D in 2024–2025. The goal: a reference score that employers, insurers and hospitals can trust, scaled by software rather than headcount, first in France, then across Europe. EIQUS detects and quantifies. It does not diagnose or treat.